Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly carboplatin + docetaxel for head and neck cancer with high comorbidity
2011-003509-65Phase 2Active
- Sponsor
- Istituto Oncologico Veneto
- Start
- Mar 2012
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of carboplatin and docetaxel in head and neck squamous cell carcinoma (HNSCC), sponsored by Istituto Oncologico Veneto. Primary endpoint: Response rate. Started Mar 2012; status: active.
02
Drugs
carboplatindocetaxel
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2011-003509-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003509-65.